Lexicon Pharmaceuticals | LXRX - 貿易債権者





貿易債権者 変化する 日付
Abbott USD 4.24B 117M 2025-12
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Akebia Therapeutics USD 21.18M 11.1M 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Coherus Biosciences USD 9.91M 14.98M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Illumina USD 218M 22M 2026-03
Insmed USD 79.91M 316K 2025-12
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
J&J USD 10.46B 1.53B 2026-03
Lexicon Pharmaceuticals USD 3.08M 714K 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
MannKind USD 9.03M 1.76M 2025-12
Merck USD 3.86B 541M 2026-03
Moderna USD 161M 156M 2026-03
Novartis USD 4.32B 134M 2026-03
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Thermo Fisher Scientific USD 3.34B 278M 2026-03
Ultragenyx Pharmaceutical USD 31M 9.57M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12